Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Harvard Business School
Medtronic
McKesson
McKinsey

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR QUETIAPINE FUMARATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Quetiapine Fumarate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00034775 ↗ A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2001-08-01 The primary purpose of the study is to assess the safety and tolerability of a long-acting injectable formulation of risperidone when switching from an oral antipsychotic in patients with schizophrenia.
NCT00060489 ↗ Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression Completed AstraZeneca Phase 3 2002-09-01 The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder.
NCT00081380 ↗ Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder Completed AstraZeneca Phase 3 2004-03-01 The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Quetiapine Fumarate

Condition Name

Condition Name for Quetiapine Fumarate
Intervention Trials
Schizophrenia 23
Bipolar Disorder 12
Major Depressive Disorder 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Quetiapine Fumarate
Intervention Trials
Disease 29
Depression 26
Schizophrenia 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Quetiapine Fumarate

Trials by Country

Trials by Country for Quetiapine Fumarate
Location Trials
United States 588
Canada 66
China 43
Korea, Republic of 21
Germany 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Quetiapine Fumarate
Location Trials
Texas 29
Florida 27
New York 26
California 26
Ohio 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Quetiapine Fumarate

Clinical Trial Phase

Clinical Trial Phase for Quetiapine Fumarate
Clinical Trial Phase Trials
Phase 4 22
Phase 3 51
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Quetiapine Fumarate
Clinical Trial Phase Trials
Completed 84
Terminated 6
Unknown status 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Quetiapine Fumarate

Sponsor Name

Sponsor Name for Quetiapine Fumarate
Sponsor Trials
AstraZeneca 68
Roxane Laboratories 3
Torrent Pharmaceuticals Limited 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Quetiapine Fumarate
Sponsor Trials
Industry 80
Other 28
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Moodys
McKinsey
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.